These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6487657)

  • 1. Polyphosphate-mediated protection from cellular intoxication with Clostridium difficile toxin B.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1984 Oct; 805(2):131-6. PubMed ID: 6487657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1983 Dec; 763(4):383-92. PubMed ID: 6652117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B.
    Florin I; Thelestam M
    Microb Pathog; 1986 Aug; 1(4):373-85. PubMed ID: 3508493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular internalisation of Clostridium difficile toxin A.
    Henriques B; Florin I; Thelestam M
    Microb Pathog; 1987 Jun; 2(6):455-63. PubMed ID: 3148814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.
    Florin I; Thelestam M
    Infect Immun; 1981 Jul; 33(1):67-74. PubMed ID: 6167521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture.
    Thelestam M; Brönnegård M
    Scand J Infect Dis Suppl; 1980; (Suppl 22):16-29. PubMed ID: 7010532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and calmodulin in cellular intoxication with Clostridium difficile toxin B.
    Caspar M; Florin I; Thelestam M
    J Cell Physiol; 1987 Jul; 132(1):168-72. PubMed ID: 3597551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
    Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
    Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1991 Jan; 1091(1):51-4. PubMed ID: 1995067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts.
    Wedel N; Toselli P; Pothoulakis C; Faris B; Oliver P; Franzblau C; LaMont T
    Exp Cell Res; 1983 Oct; 148(2):413-22. PubMed ID: 6628564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
    Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
    Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
    Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
    Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterisation of two forms of toxin B produced by Clostridium difficile.
    Torres JF; Lönnroth I
    FEBS Lett; 1988 Jun; 233(2):417-20. PubMed ID: 3133248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p38
    Schelle I; Bruening J; Buetepage M; Genth H
    Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28025502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.
    Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M
    J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
    Stubbe H; Berdoz J; Kraehenbuhl JP; Corthésy B
    J Immunol; 2000 Feb; 164(4):1952-60. PubMed ID: 10657645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
    Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
    Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
    Popoff MR
    Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.